Luv Singh, MD
Orthopaedic Surgery · Las Cruces, NMNPI 1649536830
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (58.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Smith+Nephew at 40.0% of the total. Reporting peaked in 2019 at $11,968 and has fallen 80.8% since, to $2,301 in 2025.
Across 104 payments — averaging $163.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$7K
- Stryker$4K
- Arthrex$3K
- Rattan And Associates$1K
- Sportstek Medical, Inc$776
- Vertex$176
- plus $294 from 12 others
What the payments were for
- Consulting fees$290%
- Travel & lodging$2,16113%
- Food & beverage$4,79628%
- Education$9,97058%
- Gifts$941%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 11 | $6,812 |
| Stryker(2 entities) | 50 | $4,311 |
| Arthrex | 16 | $3,292 |
| Rattan And Associates | 4 | $1,388 |
| Sportstek Medical, Inc | 1 | $776 |
| Vertex | 6 | $176 |
| Next Science LLC | 2 | $58 |
| Orthofix Medical, Inc. | 2 | $39 |
| Johnson & Johnson(2 entities) | 2 | $37 |
| Endo Pharmaceuticals Inc. | 2 | $35 |
| Vericel Corporation | 1 | $23 |
| Flower Orthopedics Coporation | 1 | $18 |
| Medtronic | 1 | $17 |
| Bioventus LLC | 1 | $16 |
| Genentech USA, Inc. | 1 | $14 |
| Merck | 1 | $14 |
| Arteriocyte Medical Systems, Inc. | 1 | $13 |
| Abbott | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$930
- Ascend Flex$644
- KNEE3 Navigation Software$436
- Navio Surgical System$433
- ADAPT$250
- AEQUALIS PERFORM REVERSED$143
- AXSOS$136
- ALLOWRAP$118
How this compares
$17,050 in reported general payments places this provider in the 85th percentile of 107 orthopaedic surgery providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 53 | $652 |
| Meloxicam | 68 | $210 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $148 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Las Cruces
- Paul SaizLas Cruces$6K
- Nathan WignerLas Cruces$6K
- Fernando RavessoudLas Cruces$6K
- Deana MercerAlbuquerque$901K
- Dan GuttmanTaos$530K
- David ChafeyAlbuquerque$108K
- Heather MenzerAlbuquerque$61K
- Ernesto Otero LopezAlbuquerque$50K
- Rick GehlertAlbuquerque$46K
- Jeffrey BeckenbaughAlbuquerque$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.